Rachelle Jacques

Elected to the board in 2022, Rachelle Jacques is the president and CEO of Akari Therapeutics PLC, a biopharmaceutical company headquartered in London. Jacques earned her Bachelor of Arts in business administration with an emphasis in accounting from Alma College in 1993.